Komori
Human Metabolome Technologies (6090) · InitiativeRestated

Strengthening the Capital Base Through a Third-Party Allotment Capital Increase

First written in FY2016-Q4. 4 of 5 entries say "Restated". Latest entry: FY2019.

5entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016-Q4 – FY20192016: 220162017: 220172018: 020182019: 12019
Same theme, other companies
Raising Funds for Growth Investments and Capital Strengthening through a Public Offering and Third-Party Allotment (Including an Overseas Offering)A theme 57 companies write about · 0 as a headwind · 57 as a tailwind

The whole theme swung hardest in 2023: 2 of 14 companies on the "Worse" side.

4 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 57 companies compared. The sentences above are computed from all 57.
Full recordFilings, disclosures and news, newest first
  1. FY2019RestatedAnnual report

    「The shortfall has been covered mainly with funds raised through the issuance of new shares by way of public offerings and third-party allotments of shares.」

    The issuance of shares, including through third-party allotments, is reaffirmed as a means of raising funds for investment in the biomarker business.
  2. FY2017RestatedAnnual report

    「Implemented a third-party allotment of shares to M3,Inc., 株式会社平田牧場, 株式会社山形銀行 and 株式会社荘内銀行 on 10 June 2016」

    The full-year changes in capital include the issuance of 430,000 shares through the third-party allotment of shares and increases of ¥178.235 million each in stated capital and the capital surplus.
  3. FY2017-Q2RestatedAnnual report

    「On 10 June 2016, the Company received payment for a third-party allotment of shares from M3,Inc., 株式会社平田牧場, 株式会社山形銀行 and 株式会社荘内銀行. As a result, during the cumulative third-quarter consolidated period, both stated capital and the capital surplus increased by ¥178.235 million.」

    The implementation of the third-party allotment of shares and the ¥178.235 million increases in stated capital and the capital surplus are restated.
  4. FY2017-Q1RestatedAnnual report

    「On 10 June 2016, the Company received payment for a third-party allotment of shares from M3,Inc., 株式会社平田牧場, 株式会社山形銀行 and 株式会社荘内銀行. As a result, during the cumulative second-quarter consolidated period, both stated capital and the capital surplus increased by ¥178.235 million.」

    The implementation of the third-party allotment of shares and the increases in stated capital and the capital surplus are restated. The disclosure also includes increases resulting from the exercise of share acquisition rights, but indicates no new change to the third-party allotment itself.
  5. FY2016-Q4First statedAnnual report

    「On 10 June 2016, the Company received payment for a third-party allotment of shares from M3,Inc., 株式会社平田牧場, 株式会社山形銀行 and 株式会社荘内銀行. As a result, during the cumulative first-quarter consolidated period, both stated capital and the capital surplus increased by ¥178.235 million.」

    The third-party allotment of shares dated 10 June 2016 increased both stated capital and the capital surplus by ¥178.235 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Strengthening the Capital Base Through a Third-Party Allotment Capital Increase | Human Metabolome Technologies,Inc. (6090) | Komori